MOORE CAPITAL MANAGEMENT, LP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 39 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$519,000
-58.3%
49,341
-61.3%
0.01%
-55.6%
Q2 2021$1,244,000
-32.9%
127,5000.0%0.02%
-21.7%
Q1 2021$1,853,000127,5000.02%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders